Philippe Giron

444 total citations
20 papers, 299 citations indexed

About

Philippe Giron is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philippe Giron has authored 20 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philippe Giron's work include Melanoma and MAPK Pathways (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Peptidase Inhibition and Analysis (3 papers). Philippe Giron is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Peptidase Inhibition and Analysis (3 papers). Philippe Giron collaborates with scholars based in Belgium, Netherlands and France. Philippe Giron's co-authors include Jacques De Grève, Amir Noeparast, Erik Teugels, Sylvia De Brakeleer, Gil Verschelden, Lore Decoster, Gustavo J. Gutierrez, Oleg Timofeev, Olivier De Wever and Martin Pichler and has published in prestigious journals such as Oncogene, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Philippe Giron

17 papers receiving 298 citations

Peers

Philippe Giron
Besnik Qeriqi United States
Utthara Nayar United States
Steven DellaRocca United States
Susmita G. Ramanand United States
Naoto Miyajima Japan
Elisabeth Emilsen Norway
Mehlika Hazar-Rethinam Australia
Hidenori Kitai Japan
Janice M. Mehnert United States
Johanne Lade‐Keller Denmark
Besnik Qeriqi United States
Philippe Giron
Citations per year, relative to Philippe Giron Philippe Giron (= 1×) peers Besnik Qeriqi

Countries citing papers authored by Philippe Giron

Since Specialization
Citations

This map shows the geographic impact of Philippe Giron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Giron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Giron more than expected).

Fields of papers citing papers by Philippe Giron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Giron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Giron. The network helps show where Philippe Giron may publish in the future.

Co-authorship network of co-authors of Philippe Giron

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Giron. A scholar is included among the top collaborators of Philippe Giron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Giron. Philippe Giron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Segers, Ingrid, Philippe Giron, Antonio Capalbo, et al.. (2025). Oocyte/zygote/embryo maturation arrest: a clinical study expanding the phenotype of NOBOX variants. Journal of Assisted Reproduction and Genetics. 42(3). 763–771.
2.
3.
Joris, Sofie, Philippe Giron, Catharina Olsen, et al.. (2024). Identification of RAD17 as a candidate cancer predisposition gene in families with histories of pancreatic and breast cancers. BMC Cancer. 24(1). 723–723. 1 indexed citations
4.
Timofeev, Oleg, Philippe Giron, Steffen Lawo, Martin Pichler, & Amir Noeparast. (2024). ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework. npj Precision Oncology. 8(1). 70–70. 25 indexed citations
5.
Messaoudi, Nouredin, Rastislav Kunda, Philippe Giron, et al.. (2023). High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer. The Journal of Pathology. 262(1). 76–89. 4 indexed citations
6.
Gutierrez, Gustavo J., et al.. (2023). Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib. Cancers. 15(9). 2589–2589. 3 indexed citations
7.
Giron, Philippe, et al.. (2022). Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells. Bioorganic & Medicinal Chemistry Letters. 79. 129066–129066. 3 indexed citations
8.
Giron, Philippe, et al.. (2022). The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer. Cell Death and Disease. 13(7). 611–611. 7 indexed citations
9.
Giron, Philippe, et al.. (2021). Structure–Activity Relationship (SAR) Study of Spautin-1 to Entail the Discovery of Novel NEK4 Inhibitors. International Journal of Molecular Sciences. 22(2). 635–635. 7 indexed citations
10.
Giron, Philippe, Maria Angeles Ceregido, Rogier Schepers, et al.. (2020). USP13 controls the stability of Aurora B impacting progression through the cell cycle. Oncogene. 39(37). 6009–6023. 23 indexed citations
11.
Giron, Philippe, Amir Noeparast, Erik Teugels, et al.. (2020). Targeting USP13‐mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non‐small cell lung cancer. International Journal of Cancer. 148(10). 2579–2593. 18 indexed citations
12.
Shintouo, Cabirou Mounchili, Robert Adamu Shey, Derrick Neba Nebangwa, et al.. (2020). In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis. Pathogens. 9(6). 495–495. 11 indexed citations
13.
Noeparast, Amir, Philippe Giron, Sylvia De Brakeleer, et al.. (2019). CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition. Oncogene. 38(31). 5933–5941. 22 indexed citations
14.
Vlaeminck, Yannick De, Quentin Lecocq, Philippe Giron, et al.. (2019). Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages. Journal of Controlled Release. 299. 107–120. 18 indexed citations
15.
Giron, Philippe, et al.. (2018). Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector. BMC Research Notes. 11(1). 751–751. 12 indexed citations
16.
17.
Umelo, Ijeoma Adaku, Peter Kronenberger, Philippe Giron, et al.. (2018). Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer. Oncotarget. 9(47). 28731–28744. 8 indexed citations
18.
Aerts, Joeri L., Jack P. Chen, Philippe Giron, et al.. (2016). Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2. Cell Death and Disease. 7(12). e2560–e2560. 24 indexed citations
19.
Noeparast, Amir, Erik Teugels, Philippe Giron, et al.. (2016). Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib. Oncotarget. 8(36). 60094–60108. 71 indexed citations
20.
Umelo, Ijeoma Adaku, Amir Noeparast, Gang Chen, et al.. (2015). Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer. Oncotarget. 7(3). 3068–3083. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Besnik Qeriqi Breakdown of academic impact, for papers by Utthara Nayar Breakdown of academic impact, for papers by Steven DellaRocca Breakdown of academic impact, for papers by Susmita G. Ramanand Breakdown of academic impact, for papers by Naoto Miyajima Breakdown of academic impact, for papers by Elisabeth Emilsen Breakdown of academic impact, for papers by Mehlika Hazar-Rethinam Breakdown of academic impact, for papers by Hidenori Kitai Breakdown of academic impact, for papers by Janice M. Mehnert Breakdown of academic impact, for papers by Johanne Lade‐Keller
Rankless by CCL
2026